Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.
暂无分享,去创建一个
E. Bruera | M. Citron | L. Constine | J. Paice | R. Portenoy | C. Miaskowski | A. Cheville | C. Lacchetti | T. Campbell | A. Cooper | P. Glare | Frank Keefe | L. Koyyalagunta | M. Levy | S. Otis‐Green | P. Sloan | F. Keefe | S. Otis-Green | Andrea Cooper | Marc Citron
[1] Bonnie Spring,et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Foster,et al. Opioid pharmacokinetic drug-drug interactions. , 2011, The American journal of managed care.
[3] Penny F Whiting,et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.
[4] Edward S. Lee,et al. Racial disparities in the monitoring of patients on chronic opioid therapy , 2013, PAIN®.
[5] P. Fayers,et al. A systematic review of oxymorphone in the management of chronic pain. , 2010, Journal of pain and symptom management.
[6] K. Kwekkeboom,et al. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. , 2010, Journal of pain and symptom management.
[7] S. Butler,et al. Development and validation of the Current Opioid Misuse Measure , 2007, PAIN.
[8] R. Portenoy. Treatment of cancer pain , 2011, The Lancet.
[9] Howard S. Smith,et al. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. , 2008, Pain physician.
[10] P. Oh,et al. [Meta-analysis of psychosocial interventions to reduce pain in patients with cancer]. , 2013, Journal of Korean Academy of Nursing.
[11] P. Moorman,et al. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. , 2013, Journal of pain and symptom management.
[12] R. Malekzadeh,et al. Opium: An emerging risk factor for gastric adenocarcinoma , 2013, International journal of cancer.
[13] H. Cabral,et al. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. , 2010, The journal of pain : official journal of the American Pain Society.
[14] H. Mead,et al. Racial and Ethnic Disparities in U.S. Health Care: A Chartbook , 2008 .
[15] J. Armer,et al. Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion. , 2011, Oncology nursing forum.
[16] Leonard J Paulozzi,et al. Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.
[17] Roger Chou,et al. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[18] D. Grobbee,et al. Long-term effects on cancer survivors’ quality of life of physical training versus physical training combined with cognitive-behavioral therapy: results from a randomized trial , 2009, Supportive Care in Cancer.
[19] M. Sullivan,et al. The missing 'P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. , 2014, General hospital psychiatry.
[20] M. Ware,et al. Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials , 2015, Journal of Neuroimmune Pharmacology.
[21] M. Taylor. The impact of the "business" of pain medicine on patient care. , 2011, Pain medicine.
[22] M. Arroyo-Morales,et al. Effectiveness of water physical therapy on pain, pressure pain sensitivity, and myofascial trigger points in breast cancer survivors: a randomized, controlled clinical trial. , 2012, Pain medicine.
[23] R. Dworkin,et al. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. , 2013, Pain medicine.
[24] T. Hart-Johnson,et al. Cancer‐related chronic pain , 2011, Cancer.
[25] R. Chou,et al. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.
[26] M. Tramèr,et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review , 2001, BMJ : British Medical Journal.
[27] E. Ernst,et al. Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials , 2012, Supportive Care in Cancer.
[28] M. Stubblefield,et al. Pain in cancer survivors. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] K. Schechtman,et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. , 2011, The Lancet. Oncology.
[30] R. Zachariae,et al. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis , 2013, Breast Cancer Research and Treatment.
[31] K. Lange,et al. Preoperative and postoperative cognitive functioning in patients with frontal meningiomas. , 2003, Journal of neurosurgery.
[32] L. Campbell,et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. , 2003, Pain medicine.
[33] K. Syrjala,et al. Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation , 2010, Journal of cancer survivorship : research and practice.
[34] S. Schnoll,et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? , 2012, Pain medicine.
[35] Hans Hansen,et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. , 2012, Pain physician.
[36] J. Kramer. Medical marijuana for cancer , 2015, CA: a cancer journal for clinicians.
[37] Jeanmarie Perrone,et al. Can prescription drug monitoring programs help limit opioid abuse? , 2011, JAMA.
[38] B. Felker,et al. Comorbid Psychiatric Disorders and Predictors of Pain Management Program Success in Patients With Chronic Pain. , 2002, Primary care companion to the Journal of clinical psychiatry.
[39] L. Gustafsson,et al. Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications , 2013, Drugs.
[40] D. Alford. Opioid Prescribing for Chronic Pain--Achieving the Right Balance through Education. , 2016, The New England journal of medicine.
[41] B. Storer,et al. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] E. Kravitz,et al. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study , 2004, Pain.
[43] Sabita Roy,et al. Role of the mu-opioid receptor in opioid modulation of immune function , 2013, Amino Acids.
[44] Todd M. Moore,et al. Validation of a new risk assessment tool: the Brief Risk Questionnaire. , 2015, Journal of opioid management.
[45] E. Bruera,et al. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer , 2014, Cancer.
[46] E. Kalso,et al. Ketamine as an adjuvant to opioids for cancer pain. , 2017, The Cochrane database of systematic reviews.
[47] J. Kleijnen,et al. Systematic review of tapentadol in chronic severe pain , 2011, Current medical research and opinion.
[48] R. Kulich,et al. Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice. , 2015, Mayo Clinic proceedings.
[49] Matt Schiller,et al. Analytic models to identify patients at risk for prescription opioid abuse. , 2009, The American journal of managed care.
[50] E. Bruera,et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. , 2012, Pain physician.
[51] B. Turner,et al. Systematic Review: Treatment Agreements and Urine Drug Testing to Reduce Opioid Misuse in Patients With Chronic Pain , 2010, Annals of Internal Medicine.
[52] S. J. Henley,et al. Invasive Cancer Incidence and Survival--United States, 2012. , 2015, MMWR. Morbidity and mortality weekly report.
[53] F. Janku,et al. The mu opioid receptor: A new target for cancer therapy? , 2015, Cancer.
[54] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[55] J. Collet,et al. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). , 2015, The journal of pain : official journal of the American Pain Society.
[56] P. Wiffen,et al. Antidepressants for neuropathic pain: a Cochrane review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[57] R. Moore,et al. Topical capsaicin (low concentration) for chronic neuropathic pain in adults , 2013, The Cochrane database of systematic reviews.
[58] Mark I. Johnson,et al. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. , 2008, The Cochrane database of systematic reviews.
[59] G. Keller,et al. Other drugs acting on nervous system associated with QT-interval prolongation. , 2010, Current drug safety.
[60] Dawn L Hershman,et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] A. Caraceni,et al. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature , 2012, Palliative medicine.
[62] R. Portenoy,et al. Principles of opioid use in cancer pain. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] R. Fillingim,et al. Chronic pain management: nonpharmacological therapies for chronic pain. , 2015, FP essentials.
[64] L. Manchikanti,et al. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? , 2006, Pain physician.
[65] S. Kaasa,et al. Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. , 2013, Journal of pain and symptom management.
[66] J. Ligibel. Physical activity for cancer survivors: meta-analysis of randomised controlled trials: Fong DYT, Ho JWC, Hui BPH, et al (Univ of Hong Kong, China; Hong Kong Polytechnic Univ, Hung Hom, Kowloon; et al) BMJ 344:e70, 2012§ , 2012 .
[67] V. Sheppard,et al. Race, Ethnicity, and Pain among the U.S. Adult Population , 2010, Journal of health care for the poor and underserved.
[68] N. Lurie,et al. Racial and Ethnic Disparities in Care: The Perspectives of Cardiologists , 2005, Circulation.
[69] R. Moore,et al. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. , 2012, The Cochrane database of systematic reviews.
[70] Ernst T. Bohlmeijer,et al. Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis , 2011, PAIN®.
[71] G. Hanks,et al. A systematic review of oxycodone in the management of cancer pain , 2011, Palliative medicine.
[72] Mark I. Johnson,et al. Acupuncture for cancer pain in adults. , 2011, The Cochrane database of systematic reviews.
[73] M. Arroyo-Morales,et al. Effectiveness of a Multidimensional Physical Therapy Program on Pain, Pressure Hypersensitivity, and Trigger Points in Breast Cancer Survivors: A Randomized Controlled Clinical Trial , 2012, The Clinical journal of pain.
[74] J. McQuade,et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[75] K. Ahrar,et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. , 2003, Journal of neurosurgery.
[76] R. Dart,et al. Trends in opioid analgesic abuse and mortality in the United States. , 2015, The New England journal of medicine.
[77] Joseph A Boscarino,et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. , 2010, Addiction.
[78] D. Hochstrasser,et al. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone , 2010, British journal of pharmacology.
[79] M. Davidsen,et al. The Danish National Cohort Study (DANCOS) , 2003, Scandinavian journal of public health.
[80] Diane D. Liu,et al. Patterns of storage, use, and disposal of opioids among cancer outpatients. , 2014, The oncologist.
[81] G. Bar-Sela,et al. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain , 2012, Palliative medicine.
[82] J. Mossey. Defining Racial and Ethnic Disparities in Pain Management , 2011, Clinical orthopaedics and related research.
[83] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .
[84] F. Chung,et al. Chronic Opioid Use and Central Sleep Apnea: A Review of the Prevalence, Mechanisms, and Perioperative Considerations , 2015, Anesthesia and analgesia.
[85] Todd M. Moore,et al. Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview. , 2013, Journal of opioid management.
[86] Howard S. Smith,et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment. , 2012, Pain physician.
[87] David Moher,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[88] P. Sacerdote,et al. Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. , 2012, Current pharmaceutical design.
[89] Laura M J Hochstenbach,et al. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. , 2016, Journal of pain and symptom management.
[90] Frank Cirrone,et al. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. , 2012, Clinical therapeutics.
[91] T. Jensen,et al. The evidence for pharmacological treatment of neuropathic pain , 2010, PAIN.
[92] B. Kapur,et al. Methadone: a review of drug-drug and pathophysiological interactions , 2011, Critical reviews in clinical laboratory sciences.
[93] S. Butler,et al. Validation of a screener and opioid assessment measure for patients with chronic pain , 2004, Pain.
[94] M. Fallon,et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. , 2010, Journal of pain and symptom management.
[95] Diane C. Calleson,et al. Racial differences in opioid use for chronic nonmalignant pain , 2005, Journal of General Internal Medicine.
[96] M. Jensen,et al. PALLIATIVE CARE SECTION Original Research Article Pain in Long-Term Breast Cancer Survivors: Frequency, Severity, and Impact , 2010 .
[97] P. Christo,et al. The influence of prescription monitoring programs on chronic pain management. , 2009, Pain physician.
[98] H. Heit,et al. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. , 2005, Pain medicine.
[99] G. Pasternak,et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.
[100] A. Ho,et al. Thoracic Paravertebral Block and Its Effects on Chronic Pain and Health-Related Quality of Life After Modified Radical Mastectomy , 2014, Regional Anesthesia & Pain Medicine.
[101] S. Rogers,et al. Exercise interventions on health‐related quality of life for cancer survivors , 2012, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[102] M. Lynch,et al. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. , 2011, British journal of clinical pharmacology.
[103] M. Bennett. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review , 2011, Palliative medicine.
[104] S. Carrara,et al. Celiac plexus block for pancreatic cancer pain in adults. , 2011, The Cochrane database of systematic reviews.
[105] D. Yee,et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. , 2002, Cancer research.
[106] Sung-Hoon Kim,et al. Meta-Analysis of Massage Therapy on Cancer Pain , 2015, Integrative cancer therapies.
[107] C. Brunelli,et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] T. Siegal,et al. Cisplatin‐induced peripheral neuropathy. Frequent off‐therapy deterioration, demyelinating syndromes, and muscle cramps , 1990, Cancer.
[109] B. Wilsey,et al. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. , 2015, The journal of pain : official journal of the American Pain Society.
[110] Duncan J Macfarlane,et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials , 2012, BMJ : British Medical Journal.
[111] G. Wilkie,et al. Medical Marijuana Use in Oncology: A Review. , 2016, JAMA oncology.
[112] Richard N Shiffman,et al. Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability , 2012, J. Am. Medical Informatics Assoc..
[113] W. Ouyang,et al. Regulatory T cells: a possible promising approach to cancer recurrence induced by morphine. , 2013, Medical hypotheses.
[114] A. Caraceni,et al. The role of hydromorphone in cancer pain treatment: a systematic review , 2011, Palliative medicine.
[115] S. Butler,et al. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). , 2008, The journal of pain : official journal of the American Pain Society.
[116] L. Manchikanti,et al. A comprehensive review of opioid-induced hyperalgesia. , 2011, Pain physician.
[117] L. Webster,et al. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. , 2005, Pain medicine.
[118] P. Wiffen,et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. , 2011, The Cochrane database of systematic reviews.
[119] R. Salgia,et al. The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer , 2014, PloS one.
[120] S. J. Henley,et al. Invasive Cancer Incidence and Survival — United States, 2011 , 2015, MMWR. Morbidity and mortality weekly report.